Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL2400081	帕拉米韦吸入溶液	peramivir	Inhalation	Chemical Drugs(2.2)	New Drug Application	2024-01-18		Langtian Pharmaceutical Technology (Wuhan) Co Ltd			view
CXHL2400082	帕拉米韦吸入溶液	peramivir	Inhalation	Chemical Drugs(2.2)	New Drug Application	2024-01-18		Langtian Pharmaceutical Technology (Wuhan) Co Ltd			view
CXHL2000106	帕拉米韦吸入溶液	peramivir	Inhalation	Chemical Drugs(2.2)	New Drug Application	2020-03-14	广州南鑫药业有限公司	Guangzhou Nanxin Pharmaceutical Co Ltd	In Review	2020-03-13	view
CXHL2000108	帕拉米韦吸入溶液	peramivir	Inhalation	Chemical Drugs(2.2)	New Drug Application	2020-03-14	广州南鑫药业有限公司	Guangzhou Nanxin Pharmaceutical Co Ltd	In Review	2020-03-13	view
CXHL2000107	帕拉米韦吸入溶液	peramivir	Inhalation	Chemical Drugs(2.2)	New Drug Application	2020-03-14	广州南鑫药业有限公司	Guangzhou Nanxin Pharmaceutical Co Ltd	In Review	2020-03-13	view